Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 14 records per page: next > | last >>
pages: 1 2 3 4 5 ... 11 12 13 14 presentations: 1 to 50 of 672
Incidence of Intended & Unintended Pregnancies Among Women With HIV on ART: 5-Year Cohort in Abidjan   (ABSTRACT 1252)
Prescilia Visi Vumba
University of Bordeaux, Bordeaux, France
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
PrEP Eligible but Missed: Preliminary Evidence Unlocking the Potential of Family Planning Services   (ABSTRACT 1255)
Brenice Duroseau
The Johns Hopkins University, Baltimore, MD, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
STAR: A Prospective Cohort of Women of Reproductive Age With and Without HIV in the Southern US   (ABSTRACT 1258)
Elizabeth F. Topper
The Johns Hopkins University, Baltimore, MD, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Neuropsychiatric Outcomes in Adults With HIV and TB on Twice-Daily BIC/FTC/TAF With Rifampicin   (ABSTRACT 951)
Gillian L. Dorse
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Plasma CNS Tissue Markers in Heavily Treatment-Experienced PWH in the PRESTIGIO Registry   (ABSTRACT 600)
Andrea Calcagno
University of Turin, Turin, Italy
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Higher suPAR Relates to Domain-Specific Cognitive Function in Virally Suppressed Women With HIV   (ABSTRACT 602)
Hemil Gonzalez
Rush University Medical Center, Chicago, IL, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Epigenetic Age Acceleration and CD4/CD8 Ratio in People With Well-Controlled HIV Infection   (ABSTRACT 867)
Alejandro de Gea Grela
Hospital La Paz Institute for Health Research, Madrid, Spain
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Validation of SARC-F Tool for Sarcopenia Screening in People Aging With HIV   (ABSTRACT 871)
Joselito Malca Hernandez
Yale University, New Haven, CT, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
TCR Convergence in HIV Controllers: Insights Into Natural Viral Suppression   (ABSTRACT 404)
Alexandra Vujkovic
Institute of Tropical Medicine, Antwerp, Belgium
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
HIV-Infection Does Not Generally Confer Higher Resistance to CTL-Mediated Lysis   (ABSTRACT 406)
Niklas Bachmann
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
HIV-Specific T & Humoral Response: Data From the First Pediatric Combined Therapeutic Vaccine Trial   (ABSTRACT 407)
Arianna Rotili
University of Rome Tor Vergata, Rome, Italy
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Patterns of Choice, Switching, and Discontinuation of Oral and Injectable PrEP Among Adolescents   (ABSTRACT 1203)
Laio Magno Santos de Sousa
Federal University of Bahia, Salvador, Brazil
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Prior Pregnancy Affects Aging-Related Non-AIDS Comorbidity Burden in US Women With and Without HIV   (ABSTRACT 988)
Lauren F. Collins
Emory University, Atlanta, GA, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
A Syndemic View of Criminal Justice: Jail’s Impact on HIV, Syphilis, and Overdose in Washington 2023   (ABSTRACT 1101)
Steven J. Erly
Washington State Department of Health, Olympia, WA, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
HIV Acquisition After Prison Release in Washington State and Implications for Prevention Efforts   (ABSTRACT 1102)
Danika A. Troupe
Washington State Department of Health, Olympia, WA, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Recent HIV Acquisition Among Transgender Women From Midwest Brazil   (ABSTRACT 1108)
Sylvia L. M. Teixeira
Oswaldo Cruz Institute – Fiocruz, Rio de Janeiro, Brazil
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Insulin-Like Growth Factors and Stunting in African Infants Exposed to HIV and Uninfected   (ABSTRACT 1022)
Brenda C. Kakayi
Makerere University–Johns Hopkins University Research Collaboration, Kampala, Uganda
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Untangling the Impact of CD101 on HIV-1 Transmission   (ABSTRACT 342)
Phuong Vo
University of Washington, Seattle, WA, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Tuberculosis Promotes the Persistence of Genetically-Intact HIV in People With HIV and Tuberculosis   (ABSTRACT 347)
Samantha K. Cronin
The University of Sydney, Sydney, Australia
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Neuropilin-1 Is Required for KSHV Lytic Replication in Primary Effusion Lymphoma   (ABSTRACT 795)
Anna Serquina
National Cancer Institute, Bethesda, MD, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Depression and Suicide Risk Among Sexual and Gender Minorities: Insights From the ImPrEP CAB Brasil   (ABSTRACT 1302)
David Richer Araujo Coelho
Massachusetts General Hospital, Boston, MA, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Estimated Benefits of Providing On-Demand PrEP Options for Women in Cape Town: A Modeling Study   (ABSTRACT 1290)
Dobromir Dimitrov
Fred Hutchinson Cancer Center, Seattle, WA, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Analyzing Neuroanatomical Heterogeneity in HIV-Associated Cognitive Impairment   (ABSTRACT 594)
Audrey Chun
Washington University in St Louis, St Louis, MO, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Monocyte Dysregulation in PASC With Ongoing Pulmonary Symptoms   (ABSTRACT 340)
Thomas K. Awamura
University of Hawaii at Manoa, Honolulu, HI, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
HIV Remission After Allogeneic Hematopoietic Stem Cell Transplant From CCR5Δ32/Δ32 Sibling Donor   (ABSTRACT 532)
Marius Trøseid
Oslo University Hospital, Oslo, Norway
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
APOL1 Genotype and Graft Function in South African HIV+-to-HIV+ Kidney Transplant Recipients   (ABSTRACT 855)
Robert Freercks
Nelson Mandela University, Gqeberha, South Africa
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Evaluating the Effectiveness and Population Impact of Status-Neutral HIV Screening in AZ   (ABSTRACT 1182)
Lazaro Ruiz
University of Arizona, Tucson, AZ, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Liver Steatosis Progression With Integrase Inhibitors in HIV Adults in Low-/Middle-Income Countries   (ABSTRACT 765)
Marie Kerbie Plaisy
University of Bordeaux, Bordeaux, France
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Epidemic of Treponema pallidum Strains in Japan and Biomarkers for Molecular Epidemiology   (ABSTRACT 1245)
Eisuke Adachi
University of Tokyo Institute of Medical Science, Tokyo, Japan
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Temsavir Treatment Improves Recognition of HIV-1 Infected Cells by Broadly Neutralizing Antibodies   (ABSTRACT 507)
Hangfei Qi
ViiV Healthcare, Durham, NC, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Disparities in COVID-19 Therapeutics Access Among People With and Without HIV: An N3C Analysis   (ABSTRACT 1097)
Emmanuel Nazaire Essam Nkodo
University of Nebraska Medical Center, Omaha, NE, USA
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
Impact of COVID-19 Pandemic in Deaths of PLWH From ART Program of a Peruvian Hospital   (ABSTRACT 1099)
Jorge Tello Arana
Universidad Científica del Sur, Lima, Peru
from CROI 2025 on March 10, 2025 2:30 PM-4:00 PM
C-Reactive Protein as a Predictor of Hospitalization and Mortality in Advanced HIV Disease in Uganda   (ABSTRACT 1136)
Elizabeth L. Schwartz
University of Minnesota, Minneapolis, MN, USA
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Perinatal and Infant Outcomes After Bictegravir Exposure in Pregnancy: A Canadian Surveillance Study   (ABSTRACT 997)
Jeffrey Man Hay Wong
University of British Columbia, Vancouver, Canada
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Impact of Initiation Delay, Duration, and Prior PrEP Usage on FTC/TDF-Containing PEP Efficacy   (ABSTRACT 1219)
Lanxin Zhang
Robert Koch Institute, Berlin, Germany
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Pharmacokinetics of Twice-Daily TAF in Adults With HIV-Associated TB on BIC/FTC/TAF and Rifampicin   (ABSTRACT 647)
Emmanuella C. Osuala
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Reduced Metformin Concentrations in Obese Women With HIV Treated With Dolutegravir   (ABSTRACT 649)
Roland van Rensburg
Stellenbosch University, Cape Town, South Africa
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Falls Associated With High Medication Regimen Complexity in People With HIV   (ABSTRACT 886)
Yunhan Chen
Boston Medical Center, Boston, MA, USA
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Sexually Transmitted Infection Prevalence Among Adolescents and Adults in Western Kenya   (ABSTRACT 1270)
Julius L. Tonzel
US Military HIV Research Program, Bethesda, MD, USA
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
HBV Seroconversion in People With HIV: Relevance of Clinical History and Viral Markers Monitoring   (ABSTRACT 775)
Marianna Menozzi
AOU Policlinico di Modena, Modena, Italy
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Predictors of Mortality Among Patients With Virus-Associated Cancers in a High HIV-Prevalence Region   (ABSTRACT 800)
Dorothy Mangale
Washington University, St Louis, MO, USA
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Autologous IgGs Mediate Log Reductions in HIV Infection in a PTC, Contributing to ART-Free Remission   (ABSTRACT 541)
Junlin Zhuo
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Afucosylation of Broadly Neutralising Antibodies to Eliminate HIV+ CD4+ T Cells and Macrophages   (ABSTRACT 542)
Morgane Brunton-O'Sullivan
Burnet Institute, Melbourne, Australia
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Engineering Natural Killer Cells With NKp30-Based Chimeric Antigen Receptors (CARs) to Target HIV   (ABSTRACT 546)
Ruoxi Pi
Stanford University, Stanford, CA, USA
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Preclinical Evaluation of Effector Function-Enhanced Variants of N6 bNAb   (ABSTRACT 547)
David Wensel
ViiV Healthcare, Branford, CT, USA
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Missed Opportunities: HIV Screening Deficits in Japanese Syphilis Patients   (ABSTRACT 1189)
Toshibumi Taniguchi
Chiba University, Chiba, Japan
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Machine Learning Risk Stratification Compared With a Counselor-Guided Screening Tool   (ABSTRACT 1190)
Daniel G. Wandina
Gold Star Kenya, Karuri, Kenya
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Contact Investigation of Incident HIV in a Population Cohort: Implications for Case Finding and PrEP   (ABSTRACT 1124)
Robert Ssekubugu
Rakai Health Sciences Program, Kalisizo, Uganda
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
New HIV-1 Diagnoses Among Different Generations of MSM in the Netherlands: Focus on Gen-Z   (ABSTRACT 1127)
Annemarie M. J. Wensing
University Medical Center Utrecht, Utrecht, Netherlands
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
Long-Term CAB+RPV LA Effectiveness in Virologically Suppressed Individuals in the OPERA Cohort   (ABSTRACT 674)
Michael Sension
CAN Community Health, Fort Lauderdale, FL, USA
from CROI 2025 on March 11, 2025 2:30 PM-4:00 PM
<< first | < prev page: of 14 records per page: next > | last >>
pages: 1 2 3 4 5 ... 11 12 13 14 presentations: 1 to 50 of 672